User profiles for Nicola Chiwandire
 | Nicola ChiwandireDepartment of Epidemiology, Vanderbilt University Medical Center Verified email at vumc.org Cited by 1183 |
[HTML][HTML] Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study
Background The SARS-CoV-2 omicron variant of concern was identified in South Africa in
November, 2021, and was associated with an increase in COVID-19 cases. We aimed to …
November, 2021, and was associated with an increase in COVID-19 cases. We aimed to …
[HTML][HTML] Clinical severity of SARS-CoV-2 Omicron BA. 4 and BA. 5 lineages compared to BA. 1 and Delta in South Africa
…, C Scheepers, N Tebeila, N Chiwandire… - Nature …, 2022 - nature.com
Omicron lineages BA.4 and BA.5 drove a fifth wave of COVID-19 cases in South Africa. Here,
we use the presence/absence of the S-gene target as a proxy for SARS-CoV-2 variant/…
we use the presence/absence of the S-gene target as a proxy for SARS-CoV-2 variant/…
[HTML][HTML] Trends, prevalence and factors associated with hypertension and diabetes among South African adults living with HIV, 2005–2017
Background Many people are now living longer with HIV due to access to antiretroviral
treatment. In turn, there has been an increase in the burden of hypertension and diabetes. The …
treatment. In turn, there has been an increase in the burden of hypertension and diabetes. The …
Changing epidemiology of Covid-19 in children and adolescents over four successive epidemic waves in South Africa, 2020–2022
Background South Africa experienced four waves of SARS-CoV-2 infection, dominated by
Wuhan-Hu, Beta, Delta, and Omicron (BA.1/BA.2). We describe the trends in SARS-CoV-2 …
Wuhan-Hu, Beta, Delta, and Omicron (BA.1/BA.2). We describe the trends in SARS-CoV-2 …
Perceptions, risk and understandings of the COVID-19 pandemic in urban South Africa
Background How people perceive the coronavirus disease 2019 (COVID-19) pandemic and
understand their risk can influence their health, behaviours and overall livelihood. The …
understand their risk can influence their health, behaviours and overall livelihood. The …
[PDF][PDF] Clinical severity of SARS-CoV-2 Omicron BA. 4 and BA. 5 lineages in South Africa
…, J Bhiman, C Scheepers, N Tebeila, N Chiwandire… - Res. Sq - academia.edu
Omicron lineages BA. 4 and BA. 5 drove a fth wave of COVID-19 cases in South Africa. We
assessed the severity of BA. 4/BA. 5 infections using the presence/absence of the S-gene …
assessed the severity of BA. 4/BA. 5 infections using the presence/absence of the S-gene …
Estimation of vaccine effectiveness against SARS-CoV-2-associated hospitalisation using sentinel surveillance in South Africa, a test-negative case-control study
N Chiwandire, S Walaza, A von Gottberg, N Wolter… - 2023 - researchsquare.com
Background COVID-19 vaccine effectiveness (VE) studies leveraging systematic surveillance
in sub-Saharan Africa are limited. We aimed to assess BNT162b2 and Ad26. COV2. S VE …
in sub-Saharan Africa are limited. We aimed to assess BNT162b2 and Ad26. COV2. S VE …
Early assessment of the clinical severity of the SARS-CoV-2 Omicron variant in South Africa (preprint)
…, J Bhiman, C Scheepers, N Tebeila, N Chiwandire… - 2021 - pesquisa.bvsalud.org
ABSTRACT Background The SARS-CoV-2 Omicron variant of concern (VOC) almost completely
replaced other variants in South Africa during November 2021, and was associated with …
replaced other variants in South Africa during November 2021, and was associated with …
[PDF][PDF] Prevalence and factors associated with hypertension and diabetes among adults living with HIV in South Africa
NV Chiwandire - 2021 - wiredspace.wits.ac.za
… I, Nicola Varaidzo Chiwandire, affirm that this research report is my work. All resources
used have been acknowledged and referenced accordingly. This research report is being …
used have been acknowledged and referenced accordingly. This research report is being …
Effectiveness of BNT162b2 and Ad. COV2. S vaccines against COVID-19-related hospitalisation among adult members of a private health insurance scheme in South …
SL Johnstone, D Shapiro, N Chiwandire, L Matoti… - 2023 - researchsquare.com
Background COVID-19 vaccine effectiveness estimates from Africa are limited. These data
can guide decisions on selecting priority groups in vaccine programs. This study estimated …
can guide decisions on selecting priority groups in vaccine programs. This study estimated …
